X

Marginal Zone Lymphoma

Marginal Zone Lymphoma

Ultrasound and Bioptic Investigation of Patients With Primary Sjögren’s Syndrome

Authors summarize the role of different imaging techniques and a bioptic approach in pSS patients, focusing mainly on the role of salivary gland ultrasonography and a US-guided core needle biopsy a

Journal of Clinical Medicine
03/11/2021
Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant

This review examines the diagnostic criteria and clinical characteristics of HCL-v and presents a comprehensive overview of current therapeutic options in HCL-v.

OncoTargets and Therapy
03/09/2021
Targeting Bruton Tyrosine Kinase Using Non-covalent Inhibitors in B Cell Malignancies

This review discusses the rationale for the use of non-covalent BTK inhibitors and the preclinical and clinical studies of non-covalent BTK inhibitors in B cell malignancies.

Journal of Hematology & Oncology
03/06/2021

Biophysical Analysis of Acute and Late Toxicity of Radiotherapy in Gastric Marginal Zone Lymphoma—Impact of Radiation Dose and Planning Target Volume

The study provides practicable data to calculate risks for neighbored organs at risk in modern radiation planning with currently lower radiation doses...

Cancers
03/19/2021
Non-Coding RNAs (miRNAs and lncRNAs) and Their Roles in Lymphogenesis in All Types of Lymphomas and Lymphoid Malignancies

The present review provides an up-to-date summary of the recent literature referring to all diagnosed ncRNAs that mediate the pathogenesis of all types of lymphomas and lymphoid malignancies.

Oncology Letters
03/18/2021
Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection

Presented here is a rare case of primary hepatic extranodal marginal zone lymphoma of MALT with underlying hepatitis B infection and present useful diagnostic findings of various imaging modalities

Medicina
03/18/2021
Dermatological Considerations in the Diagnosis and Treatment of Marginal Zone Lymphomas

The aim of this review is to describe the clinical and histological findings for the diagnosis of PC-MZL, and the state of art for the management of the patient.

03/08/2021
Efficacy and Safety of Copanlisib in Patients With Relapsed or Refractory Marginal Zone Lymphoma

Enhanced efficacy outcomes can result from prolonged duration of copanlisib therapy in patients with relapsed/refractory MZL.

Blood Advances
02/05/2021
Active Surveillance of Primary Extranodal Marginal Zone Lymphoma of Bronchus-Associated Lymphoid Tissue

This retrospective study shows that BALT lymphoma can often be managed expectantly and not require therapy for many years.

Blood Advances
01/15/2021
Durable Ibrutinib Responses in Relapsed/Refractory Marginal Zone Lymphoma: Long-Term Follow-Up and Biomarker Analysis

Study investigators find that with extended follow-up, ibrutinib demonstrates durable clinical benefit in patients with relapsed/refractory MZL.

Blood Advances
11/23/2020

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#a60538
#49cde9
#c20fce
#d95d39